[
  {
    "title": "Gilead Helps Put African Nation on Path To Eliminate Hepatitis C",
    "published": 1715089500,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 65.43000030517578,
      "2024-05-07T14:30:00+00:00": 65.56500244140625,
      "2024-05-07T15:30:00+00:00": 65.8812026977539,
      "2024-05-07T16:30:00+00:00": 65.87000274658203,
      "2024-05-07T17:30:00+00:00": 65.88999938964844,
      "2024-05-07T18:30:00+00:00": 65.8550033569336,
      "2024-05-07T19:30:00+00:00": 65.86499786376953
    },
    "sentiment": 0.80910724401474
  },
  {
    "title": "Guild Esports Joins Elite Esports World Cup",
    "published": 1715047200,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 65.43000030517578,
      "2024-05-07T14:30:00+00:00": 65.56500244140625,
      "2024-05-07T15:30:00+00:00": 65.8812026977539,
      "2024-05-07T16:30:00+00:00": 65.87000274658203,
      "2024-05-07T17:30:00+00:00": 65.88999938964844,
      "2024-05-07T18:30:00+00:00": 65.8550033569336,
      "2024-05-07T19:30:00+00:00": 65.86499786376953
    },
    "sentiment": 0.9058084487915039
  },
  {
    "title": "Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back",
    "published": 1715013543,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 64.79000091552734,
      "2024-05-06T14:30:00+00:00": 64.95210266113281,
      "2024-05-06T15:30:00+00:00": 64.4749984741211,
      "2024-05-06T16:30:00+00:00": 64.5,
      "2024-05-06T17:30:00+00:00": 64.8499984741211,
      "2024-05-06T18:30:00+00:00": 65.13500213623047,
      "2024-05-06T19:30:00+00:00": 65.16999816894531
    },
    "sentiment": 0.9032235145568848
  },
  {
    "title": "Gilead Sciences Unusual Options Activity For May 06",
    "published": 1714962060,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 64.79000091552734,
      "2024-05-06T14:30:00+00:00": 64.95210266113281,
      "2024-05-06T15:30:00+00:00": 64.4749984741211,
      "2024-05-06T16:30:00+00:00": 64.5,
      "2024-05-06T17:30:00+00:00": 64.8499984741211,
      "2024-05-06T18:30:00+00:00": 65.13500213623047,
      "2024-05-06T19:30:00+00:00": 65.16999816894531
    },
    "sentiment": 0.8084583282470703
  },
  {
    "title": "Pharma R&D productivity seen improving for the first time in years - Deloitte",
    "published": 1714790100,
    "day_prices": {},
    "sentiment": 0.9528807997703552
  },
  {
    "title": "Interesting GILD Put And Call Options For June 14th",
    "published": 1714732440,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 65.52999877929688,
      "2024-05-03T14:30:00+00:00": 64.55000305175781,
      "2024-05-03T15:30:00+00:00": 64.48999786376953,
      "2024-05-03T16:30:00+00:00": 64.42990112304688,
      "2024-05-03T17:30:00+00:00": 64.60669708251953,
      "2024-05-03T18:30:00+00:00": 64.66999816894531,
      "2024-05-03T19:30:00+00:00": 64.68000030517578
    },
    "sentiment": 0.9112786650657654
  },
  {
    "title": "Shhh! 3 Secret Biotech Stocks Flying Below Wall Street\u2019s Radar",
    "published": 1714588729,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 65.51000213623047,
      "2024-05-01T14:30:00+00:00": 65.18000030517578,
      "2024-05-01T15:30:00+00:00": 65.72000122070312,
      "2024-05-01T16:30:00+00:00": 65.41999816894531,
      "2024-05-01T17:30:00+00:00": 65.36499786376953,
      "2024-05-01T18:30:00+00:00": 65.11000061035156,
      "2024-05-01T19:30:00+00:00": 65.86000061035156
    },
    "sentiment": 0.8501288890838623
  },
  {
    "title": "Market Whales and Their Recent Bets on GILD Options",
    "published": 1715777280,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 67.94000244140625,
      "2024-05-15T14:30:00+00:00": 67.53500366210938,
      "2024-05-15T15:30:00+00:00": 67.41500091552734,
      "2024-05-15T16:30:00+00:00": 67.6500015258789,
      "2024-05-15T17:30:00+00:00": 67.72000122070312,
      "2024-05-15T18:30:00+00:00": 67.63999938964844,
      "2024-05-15T19:30:00+00:00": 67.33499908447266
    },
    "sentiment": 0.8522631525993347
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Gilead Sciences",
    "published": 1715761920,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 67.94000244140625,
      "2024-05-15T14:30:00+00:00": 67.53500366210938,
      "2024-05-15T15:30:00+00:00": 67.41500091552734,
      "2024-05-15T16:30:00+00:00": 67.6500015258789,
      "2024-05-15T17:30:00+00:00": 67.72000122070312,
      "2024-05-15T18:30:00+00:00": 67.63999938964844,
      "2024-05-15T19:30:00+00:00": 67.33499908447266
    },
    "sentiment": 0.9421179890632629
  },
  {
    "title": "Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy",
    "published": 1715695740,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 68.0,
      "2024-05-14T14:30:00+00:00": 67.37000274658203,
      "2024-05-14T15:30:00+00:00": 67.20500183105469,
      "2024-05-14T16:30:00+00:00": 67.20999908447266,
      "2024-05-14T17:30:00+00:00": 67.1500015258789,
      "2024-05-14T18:30:00+00:00": 67.5,
      "2024-05-14T19:30:00+00:00": 67.76000213623047
    },
    "sentiment": 0.9557996392250061
  },
  {
    "title": "Gilead's Kite data at EHA 2024 demonstrate 'positive' patient outcomes",
    "published": 1715678100,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 68.0,
      "2024-05-14T14:30:00+00:00": 67.37000274658203,
      "2024-05-14T15:30:00+00:00": 67.20500183105469,
      "2024-05-14T16:30:00+00:00": 67.20999908447266,
      "2024-05-14T17:30:00+00:00": 67.1500015258789,
      "2024-05-14T18:30:00+00:00": 67.5,
      "2024-05-14T19:30:00+00:00": 67.76000213623047
    },
    "sentiment": 0.9563145637512207
  },
  {
    "title": "Xilio Therapeutics expects cash to fund operations into Q2 of 2025",
    "published": 1715668680,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 68.0,
      "2024-05-14T14:30:00+00:00": 67.37000274658203,
      "2024-05-14T15:30:00+00:00": 67.20500183105469,
      "2024-05-14T16:30:00+00:00": 67.20999908447266,
      "2024-05-14T17:30:00+00:00": 67.1500015258789,
      "2024-05-14T18:30:00+00:00": 67.5,
      "2024-05-14T19:30:00+00:00": 67.76000213623047
    },
    "sentiment": 0.6320071816444397
  },
  {
    "title": "Guild Esports Converts Loan and Appoints New Secretary",
    "published": 1715564580,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 66.19000244140625,
      "2024-05-13T14:30:00+00:00": 66.80000305175781,
      "2024-05-13T15:30:00+00:00": 67.26499938964844,
      "2024-05-13T16:30:00+00:00": 67.01000213623047,
      "2024-05-13T17:30:00+00:00": 67.34429931640625,
      "2024-05-13T18:30:00+00:00": 67.23580169677734,
      "2024-05-13T19:30:00+00:00": 67.31500244140625
    },
    "sentiment": 0.8771644830703735
  },
  {
    "title": "Decoding Gilead Sciences's Options Activity: What's the Big Picture?",
    "published": 1715345820,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 64.72000122070312,
      "2024-05-10T14:30:00+00:00": 65.66999816894531,
      "2024-05-10T15:30:00+00:00": 65.76000213623047,
      "2024-05-10T16:30:00+00:00": 65.77999877929688,
      "2024-05-10T17:30:00+00:00": 66.09500122070312,
      "2024-05-10T18:30:00+00:00": 65.79000091552734,
      "2024-05-10T19:30:00+00:00": 65.92500305175781
    },
    "sentiment": 0.9310535192489624
  },
  {
    "title": "Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program",
    "published": 1715270700,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 65.1500015258789,
      "2024-05-09T14:30:00+00:00": 64.91500091552734,
      "2024-05-09T15:30:00+00:00": 64.83999633789062,
      "2024-05-09T16:30:00+00:00": 64.6500015258789,
      "2024-05-09T17:30:00+00:00": 64.83499908447266,
      "2024-05-09T18:30:00+00:00": 64.79499816894531,
      "2024-05-09T19:30:00+00:00": 64.66120147705078
    },
    "sentiment": 0.9289946556091309
  },
  {
    "title": "Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine",
    "published": 1715233800,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 65.1500015258789,
      "2024-05-09T14:30:00+00:00": 64.91500091552734,
      "2024-05-09T15:30:00+00:00": 64.83999633789062,
      "2024-05-09T16:30:00+00:00": 64.6500015258789,
      "2024-05-09T17:30:00+00:00": 64.83499908447266,
      "2024-05-09T18:30:00+00:00": 64.79499816894531,
      "2024-05-09T19:30:00+00:00": 64.66120147705078
    },
    "sentiment": 0.7897726893424988
  },
  {
    "title": "Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset",
    "published": 1715228340,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 65.1500015258789,
      "2024-05-09T14:30:00+00:00": 64.91500091552734,
      "2024-05-09T15:30:00+00:00": 64.83999633789062,
      "2024-05-09T16:30:00+00:00": 64.6500015258789,
      "2024-05-09T17:30:00+00:00": 64.83499908447266,
      "2024-05-09T18:30:00+00:00": 64.79499816894531,
      "2024-05-09T19:30:00+00:00": 64.66120147705078
    },
    "sentiment": 0.7577610015869141
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Scholar Rock Holding (SRRK), Gilead Sciences (GILD)",
    "published": 1716445260,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 67.62999725341797,
      "2024-05-23T14:30:00+00:00": 67.19000244140625,
      "2024-05-23T15:30:00+00:00": 66.75399780273438,
      "2024-05-23T16:30:00+00:00": 66.88999938964844,
      "2024-05-23T17:30:00+00:00": 66.2699966430664,
      "2024-05-23T18:30:00+00:00": 66.12999725341797,
      "2024-05-23T19:30:00+00:00": 66.22989654541016
    },
    "sentiment": 0.5328446626663208
  },
  {
    "title": "Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024",
    "published": 1716381000,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 67.18000030517578,
      "2024-05-22T14:30:00+00:00": 67.69999694824219,
      "2024-05-22T15:30:00+00:00": 67.5199966430664,
      "2024-05-22T16:30:00+00:00": 67.71050262451172,
      "2024-05-22T17:30:00+00:00": 67.84500122070312,
      "2024-05-22T18:30:00+00:00": 67.63999938964844,
      "2024-05-22T19:30:00+00:00": 67.43000030517578
    },
    "sentiment": 0.8820438385009766
  },
  {
    "title": "Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "published": 1716349620,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 67.18000030517578,
      "2024-05-22T14:30:00+00:00": 67.69999694824219,
      "2024-05-22T15:30:00+00:00": 67.5199966430664,
      "2024-05-22T16:30:00+00:00": 67.71050262451172,
      "2024-05-22T17:30:00+00:00": 67.84500122070312,
      "2024-05-22T18:30:00+00:00": 67.63999938964844,
      "2024-05-22T19:30:00+00:00": 67.43000030517578
    },
    "sentiment": 0.9133905172348022
  },
  {
    "title": "Gilead Sciences Hosts Inaugural Global Health Equity Summit",
    "published": 1716283020,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 67.79000091552734,
      "2024-05-21T14:30:00+00:00": 67.30010223388672,
      "2024-05-21T15:30:00+00:00": 67.0,
      "2024-05-21T16:30:00+00:00": 67.12999725341797,
      "2024-05-21T17:30:00+00:00": 66.88159942626953,
      "2024-05-21T18:30:00+00:00": 67.20989990234375,
      "2024-05-21T19:30:00+00:00": 67.35990142822266
    },
    "sentiment": 0.8800950050354004
  },
  {
    "title": "Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch",
    "published": 1716219376,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 67.70999908447266,
      "2024-05-20T14:30:00+00:00": 67.69860076904297,
      "2024-05-20T15:30:00+00:00": 67.69000244140625,
      "2024-05-20T16:30:00+00:00": 67.66000366210938,
      "2024-05-20T17:30:00+00:00": 67.95999908447266,
      "2024-05-20T18:30:00+00:00": 67.93000030517578,
      "2024-05-20T19:30:00+00:00": 67.94999694824219
    },
    "sentiment": 0.9486587643623352
  },
  {
    "title": "Gilead touts additional data on liver disease asset seladelpar ahead of PDUFA date",
    "published": 1716205200,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 67.70999908447266,
      "2024-05-20T14:30:00+00:00": 67.69860076904297,
      "2024-05-20T15:30:00+00:00": 67.69000244140625,
      "2024-05-20T16:30:00+00:00": 67.66000366210938,
      "2024-05-20T17:30:00+00:00": 67.95999908447266,
      "2024-05-20T18:30:00+00:00": 67.93000030517578,
      "2024-05-20T19:30:00+00:00": 67.94999694824219
    },
    "sentiment": 0.9018665552139282
  },
  {
    "title": "Seladelpar\u2019s Efficacy in PBC and Strategic Acquisition by Gilead Prompt Buy Rating",
    "published": 1716188160,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 67.70999908447266,
      "2024-05-20T14:30:00+00:00": 67.69860076904297,
      "2024-05-20T15:30:00+00:00": 67.69000244140625,
      "2024-05-20T16:30:00+00:00": 67.66000366210938,
      "2024-05-20T17:30:00+00:00": 67.95999908447266,
      "2024-05-20T18:30:00+00:00": 67.93000030517578,
      "2024-05-20T19:30:00+00:00": 67.94999694824219
    },
    "sentiment": 0.689149022102356
  },
  {
    "title": "Biopharma M&A surges year over year in Q1",
    "published": 1716080640,
    "day_prices": {},
    "sentiment": 0.924852192401886
  },
  {
    "title": "Private Equity Prowl: 3 Overlooked Stocks Primed for Buyout Bids",
    "published": 1715947560,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 67.7699966430664,
      "2024-05-17T14:30:00+00:00": 67.36060333251953,
      "2024-05-17T15:30:00+00:00": 67.5999984741211,
      "2024-05-17T16:30:00+00:00": 67.67500305175781,
      "2024-05-17T17:30:00+00:00": 67.69999694824219,
      "2024-05-17T18:30:00+00:00": 67.53500366210938,
      "2024-05-17T19:30:00+00:00": 67.52999877929688
    },
    "sentiment": 0.6810756921768188
  },
  {
    "title": "Guild Esports Signs Tekken Pro, Eyes Esports Cup",
    "published": 1715824740,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 67.01000213623047,
      "2024-05-16T14:30:00+00:00": 67.5250015258789,
      "2024-05-16T15:30:00+00:00": 67.74500274658203,
      "2024-05-16T16:30:00+00:00": 67.87680053710938,
      "2024-05-16T17:30:00+00:00": 67.80000305175781,
      "2024-05-16T18:30:00+00:00": 67.70999908447266,
      "2024-05-16T19:30:00+00:00": 67.7249984741211
    },
    "sentiment": 0.9315133094787598
  },
  {
    "title": "Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival",
    "published": 1717157614,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.6445696949958801
  },
  {
    "title": "Gilead\u2019s Trodelvy misses goal in bladder cancer study",
    "published": 1717153260,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.5098379254341125
  },
  {
    "title": "Gilead\u2019s Phase III urothelial cancer trial fails to meet primary endpoint",
    "published": 1717143922,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9239128828048706
  },
  {
    "title": "Gilead to present EVOKE-01 study data at ASCO meeting",
    "published": 1717140480,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9348657131195068
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS) and Gilead Sciences (GILD)",
    "published": 1717138260,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.8988000750541687
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)",
    "published": 1717131120,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9022720456123352
  },
  {
    "title": "Hold Rating on Gilead Sciences Amid Trodelvy Trial Setbacks and Future Uncertainties",
    "published": 1717130820,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9482693672180176
  },
  {
    "title": "Gilead Provides Update on Phase 3 TROPiCS-04 Study",
    "published": 1717101900,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 63.47999954223633,
      "2024-05-30T14:30:00+00:00": 63.415000915527344,
      "2024-05-30T15:30:00+00:00": 63.739898681640625,
      "2024-05-30T16:30:00+00:00": 63.60499954223633,
      "2024-05-30T17:30:00+00:00": 64.29000091552734,
      "2024-05-30T18:30:00+00:00": 64.05329895019531,
      "2024-05-30T19:30:00+00:00": 64.13999938964844
    },
    "sentiment": 0.9336373209953308
  },
  {
    "title": "Gilead Sciences urged to share new \"game-changer\" HIV drug",
    "published": 1717078380,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 63.47999954223633,
      "2024-05-30T14:30:00+00:00": 63.415000915527344,
      "2024-05-30T15:30:00+00:00": 63.739898681640625,
      "2024-05-30T16:30:00+00:00": 63.60499954223633,
      "2024-05-30T17:30:00+00:00": 64.29000091552734,
      "2024-05-30T18:30:00+00:00": 64.05329895019531,
      "2024-05-30T19:30:00+00:00": 64.13999938964844
    },
    "sentiment": 0.7027914524078369
  },
  {
    "title": "Gilead says Phase 3 TROPiCS-04 study did not meet primary endpoint",
    "published": 1717040940,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 63.47999954223633,
      "2024-05-30T14:30:00+00:00": 63.415000915527344,
      "2024-05-30T15:30:00+00:00": 63.739898681640625,
      "2024-05-30T16:30:00+00:00": 63.60499954223633,
      "2024-05-30T17:30:00+00:00": 64.29000091552734,
      "2024-05-30T18:30:00+00:00": 64.05329895019531,
      "2024-05-30T19:30:00+00:00": 64.13999938964844
    },
    "sentiment": 0.9067828059196472
  },
  {
    "title": "Gilead and Cartography enter deal to develop cancer therapies",
    "published": 1716977159,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 63.5,
      "2024-05-29T14:30:00+00:00": 63.209999084472656,
      "2024-05-29T15:30:00+00:00": 63.380001068115234,
      "2024-05-29T16:30:00+00:00": 63.339900970458984,
      "2024-05-29T17:30:00+00:00": 63.345001220703125,
      "2024-05-29T18:30:00+00:00": 63.380001068115234,
      "2024-05-29T19:30:00+00:00": 63.47999954223633
    },
    "sentiment": 0.623114287853241
  },
  {
    "title": "Gilead partnering with Cartography Biosciences to discover cancer therapies",
    "published": 1716888420,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 65.25,
      "2024-05-28T14:30:00+00:00": 64.86000061035156,
      "2024-05-28T15:30:00+00:00": 64.63999938964844,
      "2024-05-28T16:30:00+00:00": 64.27100372314453,
      "2024-05-28T17:30:00+00:00": 64.02999877929688,
      "2024-05-28T18:30:00+00:00": 63.96500015258789,
      "2024-05-28T19:30:00+00:00": 63.819000244140625
    },
    "sentiment": 0.6644406318664551
  },
  {
    "title": "G1 Therapeutics slips after new breast cancer data for lead asset",
    "published": 1716860280,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 65.25,
      "2024-05-28T14:30:00+00:00": 64.86000061035156,
      "2024-05-28T15:30:00+00:00": 64.63999938964844,
      "2024-05-28T16:30:00+00:00": 64.27100372314453,
      "2024-05-28T17:30:00+00:00": 64.02999877929688,
      "2024-05-28T18:30:00+00:00": 63.96500015258789,
      "2024-05-28T19:30:00+00:00": 63.819000244140625
    },
    "sentiment": 0.9477910995483398
  },
  {
    "title": "Guild Esports Navigates Economic Headwinds with Strategic Growth",
    "published": 1719538980,
    "day_prices": {
      "2024-06-28T13:30:00+00:00": 68.83000183105469,
      "2024-06-28T14:30:00+00:00": 68.83999633789062,
      "2024-06-28T15:30:00+00:00": 68.72000122070312,
      "2024-06-28T16:30:00+00:00": 68.68000030517578,
      "2024-06-28T17:30:00+00:00": 68.65499877929688,
      "2024-06-28T18:30:00+00:00": 68.73999786376953,
      "2024-06-28T19:30:00+00:00": 68.19999694824219
    },
    "sentiment": 0.5974942445755005
  },
  {
    "title": "Recent uptick might appease Gilead Sciences, Inc. (NASDAQ:GILD) institutional owners after losing 4.6% over the past year",
    "published": 1719410411,
    "day_prices": {
      "2024-06-26T13:30:00+00:00": 69.19000244140625,
      "2024-06-26T14:30:00+00:00": 69.0199966430664,
      "2024-06-26T15:30:00+00:00": 69.61000061035156,
      "2024-06-26T16:30:00+00:00": 69.51000213623047,
      "2024-06-26T17:30:00+00:00": 69.45999908447266,
      "2024-06-26T18:30:00+00:00": 69.36000061035156,
      "2024-06-26T19:30:00+00:00": 69.34500122070312
    },
    "sentiment": 0.6741739511489868
  },
  {
    "title": "Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know",
    "published": 1719352818,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 70.58000183105469,
      "2024-06-25T14:30:00+00:00": 71.00499725341797,
      "2024-06-25T15:30:00+00:00": 70.5,
      "2024-06-25T16:30:00+00:00": 70.2249984741211,
      "2024-06-25T17:30:00+00:00": 70.01000213623047,
      "2024-06-25T18:30:00+00:00": 69.91500091552734,
      "2024-06-25T19:30:00+00:00": 69.81999969482422
    },
    "sentiment": 0.6842536330223083
  },
  {
    "title": "Ideaya announces first-patient-in for Phase 1 trial of IDE397 with Trodelvy",
    "published": 1719292080,
    "day_prices": {
      "2024-06-25T13:30:00+00:00": 70.58000183105469,
      "2024-06-25T14:30:00+00:00": 71.00499725341797,
      "2024-06-25T15:30:00+00:00": 70.5,
      "2024-06-25T16:30:00+00:00": 70.2249984741211,
      "2024-06-25T17:30:00+00:00": 70.01000213623047,
      "2024-06-25T18:30:00+00:00": 69.91500091552734,
      "2024-06-25T19:30:00+00:00": 69.81999969482422
    },
    "sentiment": 0.6915802359580994
  },
  {
    "title": "Balancing Act: Gilead\u2019s HIV Success and Oncology Uncertainties Maintain Market Perform Rating",
    "published": 1719233760,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 71.0,
      "2024-06-24T14:30:00+00:00": 71.88999938964844,
      "2024-06-24T15:30:00+00:00": 71.33000183105469,
      "2024-06-24T16:30:00+00:00": 71.23999786376953,
      "2024-06-24T17:30:00+00:00": 71.18000030517578,
      "2024-06-24T18:30:00+00:00": 71.51100158691406,
      "2024-06-24T19:30:00+00:00": 71.2699966430664
    },
    "sentiment": 0.46044009923934937
  },
  {
    "title": "Gilead price target raised by $5 at Jefferies, here's why",
    "published": 1719223020,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 71.0,
      "2024-06-24T14:30:00+00:00": 71.88999938964844,
      "2024-06-24T15:30:00+00:00": 71.33000183105469,
      "2024-06-24T16:30:00+00:00": 71.23999786376953,
      "2024-06-24T17:30:00+00:00": 71.18000030517578,
      "2024-06-24T18:30:00+00:00": 71.51100158691406,
      "2024-06-24T19:30:00+00:00": 71.2699966430664
    },
    "sentiment": 0.6532853841781616
  },
  {
    "title": "Jefferies Sticks to Its Buy Rating for Gilead Sciences (GILD)",
    "published": 1719212160,
    "day_prices": {
      "2024-06-24T13:30:00+00:00": 71.0,
      "2024-06-24T14:30:00+00:00": 71.88999938964844,
      "2024-06-24T15:30:00+00:00": 71.33000183105469,
      "2024-06-24T16:30:00+00:00": 71.23999786376953,
      "2024-06-24T17:30:00+00:00": 71.18000030517578,
      "2024-06-24T18:30:00+00:00": 71.51100158691406,
      "2024-06-24T19:30:00+00:00": 71.2699966430664
    },
    "sentiment": 0.8048462867736816
  },
  {
    "title": "7 Dividend Stocks to Buy Now: June 2024",
    "published": 1719164329,
    "day_prices": {},
    "sentiment": 0.9362931251525879
  },
  {
    "title": "Why A Broken Wing Butterfly Might Make Money In Gilead Sciences Stock",
    "published": 1718998985,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 71.44999694824219,
      "2024-06-21T14:30:00+00:00": 71.27999877929688,
      "2024-06-21T15:30:00+00:00": 69.70210266113281,
      "2024-06-21T16:30:00+00:00": 69.98999786376953,
      "2024-06-21T17:30:00+00:00": 69.9749984741211,
      "2024-06-21T18:30:00+00:00": 70.25,
      "2024-06-21T19:30:00+00:00": 70.49500274658203
    },
    "sentiment": 0.9085348844528198
  },
  {
    "title": "Gilead sees encouraging results from shot to prevent HIV",
    "published": 1718977271,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 71.44999694824219,
      "2024-06-21T14:30:00+00:00": 71.27999877929688,
      "2024-06-21T15:30:00+00:00": 69.70210266113281,
      "2024-06-21T16:30:00+00:00": 69.98999786376953,
      "2024-06-21T17:30:00+00:00": 69.9749984741211,
      "2024-06-21T18:30:00+00:00": 70.25,
      "2024-06-21T19:30:00+00:00": 70.49500274658203
    },
    "sentiment": 0.9437445998191833
  },
  {
    "title": "Gilead small molecule demonstrates strong capability for HIV prevention",
    "published": 1718969472,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 71.44999694824219,
      "2024-06-21T14:30:00+00:00": 71.27999877929688,
      "2024-06-21T15:30:00+00:00": 69.70210266113281,
      "2024-06-21T16:30:00+00:00": 69.98999786376953,
      "2024-06-21T17:30:00+00:00": 69.9749984741211,
      "2024-06-21T18:30:00+00:00": 70.25,
      "2024-06-21T19:30:00+00:00": 70.49500274658203
    },
    "sentiment": 0.931926429271698
  },
  {
    "title": "Top Analyst Reports For Abbott, BP & Gilead",
    "published": 1718953320,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 71.44999694824219,
      "2024-06-21T14:30:00+00:00": 71.27999877929688,
      "2024-06-21T15:30:00+00:00": 69.70210266113281,
      "2024-06-21T16:30:00+00:00": 69.98999786376953,
      "2024-06-21T17:30:00+00:00": 69.9749984741211,
      "2024-06-21T18:30:00+00:00": 70.25,
      "2024-06-21T19:30:00+00:00": 70.49500274658203
    },
    "sentiment": 0.9358361959457397
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Silence Therapeutics (SLN) and PTC Therapeutics (PTCT)",
    "published": 1718946240,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 71.44999694824219,
      "2024-06-21T14:30:00+00:00": 71.27999877929688,
      "2024-06-21T15:30:00+00:00": 69.70210266113281,
      "2024-06-21T16:30:00+00:00": 69.98999786376953,
      "2024-06-21T17:30:00+00:00": 69.9749984741211,
      "2024-06-21T18:30:00+00:00": 70.25,
      "2024-06-21T19:30:00+00:00": 70.49500274658203
    },
    "sentiment": 0.9093952178955078
  },
  {
    "title": "Gilead Sciences Stock (GILD) Gained on Promising Trial Results",
    "published": 1718944860,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 71.44999694824219,
      "2024-06-21T14:30:00+00:00": 71.27999877929688,
      "2024-06-21T15:30:00+00:00": 69.70210266113281,
      "2024-06-21T16:30:00+00:00": 69.98999786376953,
      "2024-06-21T17:30:00+00:00": 69.9749984741211,
      "2024-06-21T18:30:00+00:00": 70.25,
      "2024-06-21T19:30:00+00:00": 70.49500274658203
    },
    "sentiment": 0.9518887400627136
  },
  {
    "title": "Notable Friday Option Activity: GILD, ADBE, HUBS",
    "published": 1718936340,
    "day_prices": {
      "2024-06-21T13:30:00+00:00": 71.44999694824219,
      "2024-06-21T14:30:00+00:00": 71.27999877929688,
      "2024-06-21T15:30:00+00:00": 69.70210266113281,
      "2024-06-21T16:30:00+00:00": 69.98999786376953,
      "2024-06-21T17:30:00+00:00": 69.9749984741211,
      "2024-06-21T18:30:00+00:00": 70.25,
      "2024-06-21T19:30:00+00:00": 70.49500274658203
    },
    "sentiment": 0.8802312016487122
  },
  {
    "title": "Gilead\u2019s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.",
    "published": 1718914860,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.9159423112869263
  },
  {
    "title": "Gilead Sciences stock jumps on HIV treatment trial success",
    "published": 1718914198,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.6231012940406799
  },
  {
    "title": "Gilead Stock Surges on Strong Results in HIV Drug Study",
    "published": 1718910847,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.917277991771698
  },
  {
    "title": "Why Wall Street Is Chasing Ozempic Wannabes",
    "published": 1718881200,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.9091622233390808
  },
  {
    "title": "Gilead's Twice-Yearly Shot Prevents HIV",
    "published": 1718901623,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.779098629951477
  },
  {
    "title": "Health Care Stocks Rise Behind Gilead -- Health Care Roundup",
    "published": 1718900846,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.5238809585571289
  },
  {
    "title": "Gilead Stock Gets Boost from HIV Drug Study Results",
    "published": 1718898443,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.9431517720222473
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It",
    "published": 1718888411,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.9304423928260803
  },
  {
    "title": "Baird says incrementally positive on Gilead given PURPOSE 1 study data",
    "published": 1718880120,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.9431542158126831
  },
  {
    "title": "KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday",
    "published": 1718875560,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.9465248584747314
  },
  {
    "title": "Gilead's long-acting HIV drug superior to daily pill Truvada in study",
    "published": 1718873515,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.9185695648193359
  },
  {
    "title": "Gilead announces Phase 3 PURPOSE 1 trial met key efficiency endpoints",
    "published": 1718870280,
    "day_prices": {
      "2024-06-20T13:30:00+00:00": 64.86000061035156,
      "2024-06-20T14:30:00+00:00": 65.98999786376953,
      "2024-06-20T15:30:00+00:00": 67.94000244140625,
      "2024-06-20T16:30:00+00:00": 68.0,
      "2024-06-20T17:30:00+00:00": 69.19999694824219,
      "2024-06-20T18:30:00+00:00": 67.96959686279297,
      "2024-06-20T19:30:00+00:00": 68.48500061035156
    },
    "sentiment": 0.8980904221534729
  },
  {
    "title": "Gilead\u2019s HIV prevention treatment found 100% effective in late-stage trial",
    "published": 1718837100,
    "day_prices": {},
    "sentiment": 0.920478343963623
  },
  {
    "title": "$100 Invested In This Stock 20 Years Ago Would Be Worth $800 Today",
    "published": 1718761080,
    "day_prices": {},
    "sentiment": 0.9417252540588379
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Intra-Cellular Therapies (ITCI), Gilead Sciences (GILD)",
    "published": 1718710860,
    "day_prices": {
      "2024-06-18T13:30:00+00:00": 64.19999694824219,
      "2024-06-18T14:30:00+00:00": 63.540000915527344,
      "2024-06-18T15:30:00+00:00": 63.369998931884766,
      "2024-06-18T16:30:00+00:00": 62.970001220703125,
      "2024-06-18T17:30:00+00:00": 63.279998779296875,
      "2024-06-18T18:30:00+00:00": 63.349998474121094,
      "2024-06-18T19:30:00+00:00": 62.709999084472656
    },
    "sentiment": 0.5861444473266602
  },
  {
    "title": "Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender",
    "published": 1718654553,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 64.7249984741211,
      "2024-06-17T14:30:00+00:00": 64.51000213623047,
      "2024-06-17T15:30:00+00:00": 64.55999755859375,
      "2024-06-17T16:30:00+00:00": 64.66999816894531,
      "2024-06-17T17:30:00+00:00": 64.68000030517578,
      "2024-06-17T18:30:00+00:00": 64.79499816894531,
      "2024-06-17T19:30:00+00:00": 64.58999633789062
    },
    "sentiment": 0.6476516127586365
  },
  {
    "title": "New Kite Clinical Research and Real-World Evidence for Yescarta Demonstrate Benefit from Earlier Lines of Treatment",
    "published": 1718622915,
    "day_prices": {
      "2024-06-17T13:30:00+00:00": 64.7249984741211,
      "2024-06-17T14:30:00+00:00": 64.51000213623047,
      "2024-06-17T15:30:00+00:00": 64.55999755859375,
      "2024-06-17T16:30:00+00:00": 64.66999816894531,
      "2024-06-17T17:30:00+00:00": 64.68000030517578,
      "2024-06-17T18:30:00+00:00": 64.79499816894531,
      "2024-06-17T19:30:00+00:00": 64.58999633789062
    },
    "sentiment": 0.9109702706336975
  },
  {
    "title": "2 June Bargains With Up To 7.6% Yield",
    "published": 1718442000,
    "day_prices": {},
    "sentiment": 0.807628333568573
  },
  {
    "title": "Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup",
    "published": 1718386094,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 62.819801330566406,
      "2024-06-14T14:30:00+00:00": 64.29000091552734,
      "2024-06-14T15:30:00+00:00": 64.5199966430664,
      "2024-06-14T16:30:00+00:00": 64.63999938964844,
      "2024-06-14T17:30:00+00:00": 64.58000183105469,
      "2024-06-14T18:30:00+00:00": 64.9800033569336,
      "2024-06-14T19:30:00+00:00": 65.04000091552734
    },
    "sentiment": 0.8906230926513672
  },
  {
    "title": "Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar",
    "published": 1718381404,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 62.819801330566406,
      "2024-06-14T14:30:00+00:00": 64.29000091552734,
      "2024-06-14T15:30:00+00:00": 64.5199966430664,
      "2024-06-14T16:30:00+00:00": 64.63999938964844,
      "2024-06-14T17:30:00+00:00": 64.58000183105469,
      "2024-06-14T18:30:00+00:00": 64.9800033569336,
      "2024-06-14T19:30:00+00:00": 65.04000091552734
    },
    "sentiment": 0.7381322383880615
  },
  {
    "title": "Gilead Sciences Inc's Dividend Analysis",
    "published": 1718362891,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 62.819801330566406,
      "2024-06-14T14:30:00+00:00": 64.29000091552734,
      "2024-06-14T15:30:00+00:00": 64.5199966430664,
      "2024-06-14T16:30:00+00:00": 64.63999938964844,
      "2024-06-14T17:30:00+00:00": 64.58000183105469,
      "2024-06-14T18:30:00+00:00": 64.9800033569336,
      "2024-06-14T19:30:00+00:00": 65.04000091552734
    },
    "sentiment": 0.9390841722488403
  },
  {
    "title": "Gilead spikes as Jefferies highlights weight loss prospects",
    "published": 1718360700,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 62.819801330566406,
      "2024-06-14T14:30:00+00:00": 64.29000091552734,
      "2024-06-14T15:30:00+00:00": 64.5199966430664,
      "2024-06-14T16:30:00+00:00": 64.63999938964844,
      "2024-06-14T17:30:00+00:00": 64.58000183105469,
      "2024-06-14T18:30:00+00:00": 64.9800033569336,
      "2024-06-14T19:30:00+00:00": 65.04000091552734
    },
    "sentiment": 0.5750429630279541
  },
  {
    "title": "New data on Gilead oral GLP-1 coming at conference next week, says Jefferies",
    "published": 1718359140,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 62.819801330566406,
      "2024-06-14T14:30:00+00:00": 64.29000091552734,
      "2024-06-14T15:30:00+00:00": 64.5199966430664,
      "2024-06-14T16:30:00+00:00": 64.63999938964844,
      "2024-06-14T17:30:00+00:00": 64.58000183105469,
      "2024-06-14T18:30:00+00:00": 64.9800033569336,
      "2024-06-14T19:30:00+00:00": 65.04000091552734
    },
    "sentiment": 0.8751288652420044
  },
  {
    "title": "New Kite Clinical Research and Real-World Evidence for Yescarta\u00ae Demonstrate Benefit From Earlier Lines of Treatment",
    "published": 1718348400,
    "day_prices": {
      "2024-06-14T13:30:00+00:00": 62.819801330566406,
      "2024-06-14T14:30:00+00:00": 64.29000091552734,
      "2024-06-14T15:30:00+00:00": 64.5199966430664,
      "2024-06-14T16:30:00+00:00": 64.63999938964844,
      "2024-06-14T17:30:00+00:00": 64.58000183105469,
      "2024-06-14T18:30:00+00:00": 64.9800033569336,
      "2024-06-14T19:30:00+00:00": 65.04000091552734
    },
    "sentiment": 0.8767411708831787
  },
  {
    "title": "Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts",
    "published": 1718316019,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 64.05000305175781,
      "2024-06-13T14:30:00+00:00": 63.94499969482422,
      "2024-06-13T15:30:00+00:00": 63.869998931884766,
      "2024-06-13T16:30:00+00:00": 63.689998626708984,
      "2024-06-13T17:30:00+00:00": 63.810001373291016,
      "2024-06-13T18:30:00+00:00": 64.0199966430664,
      "2024-06-13T19:30:00+00:00": 63.81999969482422
    },
    "sentiment": 0.8435472249984741
  },
  {
    "title": "Guild Esports Charges Into Esports World Cup",
    "published": 1718243160,
    "day_prices": {
      "2024-06-13T13:30:00+00:00": 64.05000305175781,
      "2024-06-13T14:30:00+00:00": 63.94499969482422,
      "2024-06-13T15:30:00+00:00": 63.869998931884766,
      "2024-06-13T16:30:00+00:00": 63.689998626708984,
      "2024-06-13T17:30:00+00:00": 63.810001373291016,
      "2024-06-13T18:30:00+00:00": 64.0199966430664,
      "2024-06-13T19:30:00+00:00": 63.81999969482422
    },
    "sentiment": 0.9092665910720825
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)",
    "published": 1718226007,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 64.98999786376953,
      "2024-06-12T14:30:00+00:00": 64.2249984741211,
      "2024-06-12T15:30:00+00:00": 64.11499786376953,
      "2024-06-12T16:30:00+00:00": 64.31990051269531,
      "2024-06-12T17:30:00+00:00": 64.33499908447266,
      "2024-06-12T18:30:00+00:00": 64.20999908447266,
      "2024-06-12T19:30:00+00:00": 63.880001068115234
    },
    "sentiment": 0.9247698783874512
  },
  {
    "title": "Ex-Dividend Reminder: Gilead Sciences, HCA Healthcare and CONMED",
    "published": 1718189820,
    "day_prices": {
      "2024-06-12T13:30:00+00:00": 64.98999786376953,
      "2024-06-12T14:30:00+00:00": 64.2249984741211,
      "2024-06-12T15:30:00+00:00": 64.11499786376953,
      "2024-06-12T16:30:00+00:00": 64.31990051269531,
      "2024-06-12T17:30:00+00:00": 64.33499908447266,
      "2024-06-12T18:30:00+00:00": 64.20999908447266,
      "2024-06-12T19:30:00+00:00": 63.880001068115234
    },
    "sentiment": 0.9549803137779236
  },
  {
    "title": "Ex-Dividend Date Nearing for These 10 Stocks \u2013 Week of June 10, 2024",
    "published": 1717915020,
    "day_prices": {},
    "sentiment": 0.9451963305473328
  },
  {
    "title": "AstraZeneca dominates, Merck\u2019s Keytruda beaten as ASCO 2024 concludes",
    "published": 1717838520,
    "day_prices": {},
    "sentiment": 0.7508275508880615
  },
  {
    "title": "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know",
    "published": 1717797013,
    "day_prices": {
      "2024-06-07T13:30:00+00:00": 63.79999923706055,
      "2024-06-07T14:30:00+00:00": 64.58000183105469,
      "2024-06-07T15:30:00+00:00": 64.66999816894531,
      "2024-06-07T16:30:00+00:00": 64.69999694824219,
      "2024-06-07T17:30:00+00:00": 64.75,
      "2024-06-07T18:30:00+00:00": 64.83000183105469,
      "2024-06-07T19:30:00+00:00": 64.73500061035156
    },
    "sentiment": 0.7556019425392151
  },
  {
    "title": "Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know",
    "published": 1717678812,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 63.79999923706055,
      "2024-06-06T14:30:00+00:00": 63.880001068115234,
      "2024-06-06T15:30:00+00:00": 63.90999984741211,
      "2024-06-06T16:30:00+00:00": 63.900001525878906,
      "2024-06-06T17:30:00+00:00": 63.93000030517578,
      "2024-06-06T18:30:00+00:00": 63.95000076293945,
      "2024-06-06T19:30:00+00:00": 63.89030075073242
    },
    "sentiment": 0.9385344982147217
  },
  {
    "title": "Gilead Says Bulevirtide With PegIFN Data 'Superior' to Bulevirtide Monotherapy; Achieves 46% Rate of Undetectable HDV RNA",
    "published": 1717676081,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 63.79999923706055,
      "2024-06-06T14:30:00+00:00": 63.880001068115234,
      "2024-06-06T15:30:00+00:00": 63.90999984741211,
      "2024-06-06T16:30:00+00:00": 63.900001525878906,
      "2024-06-06T17:30:00+00:00": 63.93000030517578,
      "2024-06-06T18:30:00+00:00": 63.95000076293945,
      "2024-06-06T19:30:00+00:00": 63.89030075073242
    },
    "sentiment": 0.9529204368591309
  },
  {
    "title": "Gilead's Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis",
    "published": 1717669295,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 63.79999923706055,
      "2024-06-06T14:30:00+00:00": 63.880001068115234,
      "2024-06-06T15:30:00+00:00": 63.90999984741211,
      "2024-06-06T16:30:00+00:00": 63.900001525878906,
      "2024-06-06T17:30:00+00:00": 63.93000030517578,
      "2024-06-06T18:30:00+00:00": 63.95000076293945,
      "2024-06-06T19:30:00+00:00": 63.89030075073242
    },
    "sentiment": 0.9491825699806213
  },
  {
    "title": "Gilead\u2019s seladelpar shows promise in primary biliary cholangitis trial",
    "published": 1717663546,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 63.79999923706055,
      "2024-06-06T14:30:00+00:00": 63.880001068115234,
      "2024-06-06T15:30:00+00:00": 63.90999984741211,
      "2024-06-06T16:30:00+00:00": 63.900001525878906,
      "2024-06-06T17:30:00+00:00": 63.93000030517578,
      "2024-06-06T18:30:00+00:00": 63.95000076293945,
      "2024-06-06T19:30:00+00:00": 63.89030075073242
    },
    "sentiment": 0.9178522825241089
  },
  {
    "title": "Analysts Are Bullish on These Healthcare Stocks: Option Care Health (OPCH), Gilead Sciences (GILD)",
    "published": 1717657920,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 63.79999923706055,
      "2024-06-06T14:30:00+00:00": 63.880001068115234,
      "2024-06-06T15:30:00+00:00": 63.90999984741211,
      "2024-06-06T16:30:00+00:00": 63.900001525878906,
      "2024-06-06T17:30:00+00:00": 63.93000030517578,
      "2024-06-06T18:30:00+00:00": 63.95000076293945,
      "2024-06-06T19:30:00+00:00": 63.89030075073242
    },
    "sentiment": 0.5649189352989197
  },
  {
    "title": "Gilead publishes MYR204 study data in New England Journal of Medicine",
    "published": 1717646820,
    "day_prices": {
      "2024-06-06T13:30:00+00:00": 63.79999923706055,
      "2024-06-06T14:30:00+00:00": 63.880001068115234,
      "2024-06-06T15:30:00+00:00": 63.90999984741211,
      "2024-06-06T16:30:00+00:00": 63.900001525878906,
      "2024-06-06T17:30:00+00:00": 63.93000030517578,
      "2024-06-06T18:30:00+00:00": 63.95000076293945,
      "2024-06-06T19:30:00+00:00": 63.89030075073242
    },
    "sentiment": 0.9306906461715698
  },
  {
    "title": "Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?",
    "published": 1717595100,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 64.16999816894531,
      "2024-06-05T14:30:00+00:00": 63.459999084472656,
      "2024-06-05T15:30:00+00:00": 64.16000366210938,
      "2024-06-05T16:30:00+00:00": 64.05000305175781,
      "2024-06-05T17:30:00+00:00": 64.08000183105469,
      "2024-06-05T18:30:00+00:00": 64.03500366210938,
      "2024-06-05T19:30:00+00:00": 63.9900016784668
    },
    "sentiment": 0.9211837649345398
  },
  {
    "title": "Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks",
    "published": 1717588500,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 64.16999816894531,
      "2024-06-05T14:30:00+00:00": 63.459999084472656,
      "2024-06-05T15:30:00+00:00": 64.16000366210938,
      "2024-06-05T16:30:00+00:00": 64.05000305175781,
      "2024-06-05T17:30:00+00:00": 64.08000183105469,
      "2024-06-05T18:30:00+00:00": 64.03500366210938,
      "2024-06-05T19:30:00+00:00": 63.9900016784668
    },
    "sentiment": 0.9285397529602051
  },
  {
    "title": "7 Dividend Stocks to Invest In for a Lifetime of Income",
    "published": 1717584000,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 64.16999816894531,
      "2024-06-05T14:30:00+00:00": 63.459999084472656,
      "2024-06-05T15:30:00+00:00": 64.16000366210938,
      "2024-06-05T16:30:00+00:00": 64.05000305175781,
      "2024-06-05T17:30:00+00:00": 64.08000183105469,
      "2024-06-05T18:30:00+00:00": 64.03500366210938,
      "2024-06-05T19:30:00+00:00": 63.9900016784668
    },
    "sentiment": 0.930995762348175
  },
  {
    "title": "J&J seeks expanded approvals for paediatric HIV-1 therapy",
    "published": 1717575944,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 64.16999816894531,
      "2024-06-05T14:30:00+00:00": 63.459999084472656,
      "2024-06-05T15:30:00+00:00": 64.16000366210938,
      "2024-06-05T16:30:00+00:00": 64.05000305175781,
      "2024-06-05T17:30:00+00:00": 64.08000183105469,
      "2024-06-05T18:30:00+00:00": 64.03500366210938,
      "2024-06-05T19:30:00+00:00": 63.9900016784668
    },
    "sentiment": 0.9334074258804321
  },
  {
    "title": "Gilead announces two-year interim results from ASSURE study",
    "published": 1717562280,
    "day_prices": {
      "2024-06-05T13:30:00+00:00": 64.16999816894531,
      "2024-06-05T14:30:00+00:00": 63.459999084472656,
      "2024-06-05T15:30:00+00:00": 64.16000366210938,
      "2024-06-05T16:30:00+00:00": 64.05000305175781,
      "2024-06-05T17:30:00+00:00": 64.08000183105469,
      "2024-06-05T18:30:00+00:00": 64.03500366210938,
      "2024-06-05T19:30:00+00:00": 63.9900016784668
    },
    "sentiment": 0.6613365411758423
  },
  {
    "title": "National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention Injection",
    "published": 1717531044,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 63.5,
      "2024-06-04T14:30:00+00:00": 64.33000183105469,
      "2024-06-04T15:30:00+00:00": 64.0,
      "2024-06-04T16:30:00+00:00": 63.790000915527344,
      "2024-06-04T17:30:00+00:00": 63.9900016784668,
      "2024-06-04T18:30:00+00:00": 64.2300033569336,
      "2024-06-04T19:30:00+00:00": 63.95500183105469
    },
    "sentiment": 0.6875112652778625
  },
  {
    "title": "The Zacks Analyst Blog Highlights NextEra Energy, BP, Gilead Sciences, Hamilton Beach and FONAR",
    "published": 1717506660,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 63.5,
      "2024-06-04T14:30:00+00:00": 64.33000183105469,
      "2024-06-04T15:30:00+00:00": 64.0,
      "2024-06-04T16:30:00+00:00": 63.790000915527344,
      "2024-06-04T17:30:00+00:00": 63.9900016784668,
      "2024-06-04T18:30:00+00:00": 64.2300033569336,
      "2024-06-04T19:30:00+00:00": 63.95500183105469
    },
    "sentiment": 0.9367176294326782
  },
  {
    "title": "Gilead reached agreement in principle to resolve federal TDF litigation",
    "published": 1717486800,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 63.5,
      "2024-06-04T14:30:00+00:00": 64.33000183105469,
      "2024-06-04T15:30:00+00:00": 64.0,
      "2024-06-04T16:30:00+00:00": 63.790000915527344,
      "2024-06-04T17:30:00+00:00": 63.9900016784668,
      "2024-06-04T18:30:00+00:00": 64.2300033569336,
      "2024-06-04T19:30:00+00:00": 63.95500183105469
    },
    "sentiment": 0.9380872845649719
  },
  {
    "title": "Gilead Sciences Receives Hold Rating Amid Trodelvy Trial Setbacks",
    "published": 1717470600,
    "day_prices": {
      "2024-06-04T13:30:00+00:00": 63.5,
      "2024-06-04T14:30:00+00:00": 64.33000183105469,
      "2024-06-04T15:30:00+00:00": 64.0,
      "2024-06-04T16:30:00+00:00": 63.790000915527344,
      "2024-06-04T17:30:00+00:00": 63.9900016784668,
      "2024-06-04T18:30:00+00:00": 64.2300033569336,
      "2024-06-04T19:30:00+00:00": 63.95500183105469
    },
    "sentiment": 0.9570841193199158
  },
  {
    "title": "Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study",
    "published": 1717437540,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 64.30999755859375,
      "2024-06-03T14:30:00+00:00": 64.62000274658203,
      "2024-06-03T15:30:00+00:00": 64.0199966430664,
      "2024-06-03T16:30:00+00:00": 63.470001220703125,
      "2024-06-03T17:30:00+00:00": 63.349998474121094,
      "2024-06-03T18:30:00+00:00": 63.599998474121094,
      "2024-06-03T19:30:00+00:00": 63.57500076293945
    },
    "sentiment": 0.8941566944122314
  },
  {
    "title": "Gilead immunotherapies effective against rare and aggressive cancers",
    "published": 1717430040,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 64.30999755859375,
      "2024-06-03T14:30:00+00:00": 64.62000274658203,
      "2024-06-03T15:30:00+00:00": 64.0199966430664,
      "2024-06-03T16:30:00+00:00": 63.470001220703125,
      "2024-06-03T17:30:00+00:00": 63.349998474121094,
      "2024-06-03T18:30:00+00:00": 63.599998474121094,
      "2024-06-03T19:30:00+00:00": 63.57500076293945
    },
    "sentiment": 0.6644101738929749
  },
  {
    "title": "Encouraging New Data Presented on Kite\u2019s Yescarta\u00ae for Relapsed/Refractory Central Nervous System Lymphoma",
    "published": 1717419600,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 64.30999755859375,
      "2024-06-03T14:30:00+00:00": 64.62000274658203,
      "2024-06-03T15:30:00+00:00": 64.0199966430664,
      "2024-06-03T16:30:00+00:00": 63.470001220703125,
      "2024-06-03T17:30:00+00:00": 63.349998474121094,
      "2024-06-03T18:30:00+00:00": 63.599998474121094,
      "2024-06-03T19:30:00+00:00": 63.57500076293945
    },
    "sentiment": 0.5452433824539185
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Immutep Ltd (OtherPRRUF)",
    "published": 1717398660,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 64.30999755859375,
      "2024-06-03T14:30:00+00:00": 64.62000274658203,
      "2024-06-03T15:30:00+00:00": 64.0199966430664,
      "2024-06-03T16:30:00+00:00": 63.470001220703125,
      "2024-06-03T17:30:00+00:00": 63.349998474121094,
      "2024-06-03T18:30:00+00:00": 63.599998474121094,
      "2024-06-03T19:30:00+00:00": 63.57500076293945
    },
    "sentiment": 0.8958023190498352
  },
  {
    "title": "Gilead Sciences: A Buy Rating Amidst Oncology Advancements and Solid HIV Business",
    "published": 1717396140,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 64.30999755859375,
      "2024-06-03T14:30:00+00:00": 64.62000274658203,
      "2024-06-03T15:30:00+00:00": 64.0199966430664,
      "2024-06-03T16:30:00+00:00": 63.470001220703125,
      "2024-06-03T17:30:00+00:00": 63.349998474121094,
      "2024-06-03T18:30:00+00:00": 63.599998474121094,
      "2024-06-03T19:30:00+00:00": 63.57500076293945
    },
    "sentiment": 0.5745334029197693
  },
  {
    "title": "Gilead, Arcus combo significantly reduces death risk in colorectal cancer",
    "published": 1717376520,
    "day_prices": {
      "2024-06-03T13:30:00+00:00": 64.30999755859375,
      "2024-06-03T14:30:00+00:00": 64.62000274658203,
      "2024-06-03T15:30:00+00:00": 64.0199966430664,
      "2024-06-03T16:30:00+00:00": 63.470001220703125,
      "2024-06-03T17:30:00+00:00": 63.349998474121094,
      "2024-06-03T18:30:00+00:00": 63.599998474121094,
      "2024-06-03T19:30:00+00:00": 63.57500076293945
    },
    "sentiment": 0.9229507446289062
  },
  {
    "title": "Gilead, Arcus announce new data from Cohort B of ARC-9 mCRC study",
    "published": 1717313460,
    "day_prices": {},
    "sentiment": 0.8739894032478333
  },
  {
    "title": "Gilead, Arcus announce data supporting ongoing Phase 3 STAR-221 study",
    "published": 1717307280,
    "day_prices": {},
    "sentiment": 0.5667411088943481
  },
  {
    "title": "Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock",
    "published": 1722430812,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 77.44000244140625,
      "2024-07-31T14:30:00+00:00": 77.69999694824219,
      "2024-07-31T15:30:00+00:00": 77.54000091552734,
      "2024-07-31T16:30:00+00:00": 77.31999969482422,
      "2024-07-31T17:30:00+00:00": 77.08999633789062,
      "2024-07-31T18:30:00+00:00": 76.94999694824219,
      "2024-07-31T19:30:00+00:00": 76.56999969482422
    },
    "sentiment": 0.9143447279930115
  },
  {
    "title": "Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?",
    "published": 1722405780,
    "day_prices": {
      "2024-07-31T13:30:00+00:00": 77.44000244140625,
      "2024-07-31T14:30:00+00:00": 77.69999694824219,
      "2024-07-31T15:30:00+00:00": 77.54000091552734,
      "2024-07-31T16:30:00+00:00": 77.31999969482422,
      "2024-07-31T17:30:00+00:00": 77.08999633789062,
      "2024-07-31T18:30:00+00:00": 76.94999694824219,
      "2024-07-31T19:30:00+00:00": 76.56999969482422
    },
    "sentiment": 0.9267992377281189
  },
  {
    "title": "Compugen receives FDA approval for Phase I trial of solid tumour treatment",
    "published": 1722336771,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 77.41999816894531,
      "2024-07-30T14:30:00+00:00": 77.62000274658203,
      "2024-07-30T15:30:00+00:00": 77.43000030517578,
      "2024-07-30T16:30:00+00:00": 77.62000274658203,
      "2024-07-30T17:30:00+00:00": 77.80999755859375,
      "2024-07-30T18:30:00+00:00": 78.12239837646484,
      "2024-07-30T19:30:00+00:00": 78.1500015258789
    },
    "sentiment": 0.934767484664917
  },
  {
    "title": "Gilead Sciences's Options Frenzy: What You Need to Know",
    "published": 1722301440,
    "day_prices": {
      "2024-07-30T13:30:00+00:00": 77.41999816894531,
      "2024-07-30T14:30:00+00:00": 77.62000274658203,
      "2024-07-30T15:30:00+00:00": 77.43000030517578,
      "2024-07-30T16:30:00+00:00": 77.62000274658203,
      "2024-07-30T17:30:00+00:00": 77.80999755859375,
      "2024-07-30T18:30:00+00:00": 78.12239837646484,
      "2024-07-30T19:30:00+00:00": 78.1500015258789
    },
    "sentiment": 0.94484543800354
  },
  {
    "title": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "published": 1722258011,
    "day_prices": {
      "2024-07-29T13:30:00+00:00": 77.12000274658203,
      "2024-07-29T14:30:00+00:00": 77.19000244140625,
      "2024-07-29T15:30:00+00:00": 77.375,
      "2024-07-29T16:30:00+00:00": 77.69010162353516,
      "2024-07-29T17:30:00+00:00": 77.78500366210938,
      "2024-07-29T18:30:00+00:00": 77.58000183105469,
      "2024-07-29T19:30:00+00:00": 77.55000305175781
    },
    "sentiment": 0.7656295299530029
  },
  {
    "title": "Most U.S. pharmas don't pay any U.S. income tax",
    "published": 1722157320,
    "day_prices": {},
    "sentiment": 0.9261672496795654
  },
  {
    "title": "A Look At Gilead Sciences After Its Recent Weakness",
    "published": 1722050313,
    "day_prices": {},
    "sentiment": 0.8853968977928162
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Align Tech (ALGN) and Gilead Sciences (GILD)",
    "published": 1721960340,
    "day_prices": {
      "2024-07-26T13:30:00+00:00": 76.02999877929688,
      "2024-07-26T14:30:00+00:00": 77.19000244140625,
      "2024-07-26T15:30:00+00:00": 77.4800033569336,
      "2024-07-26T16:30:00+00:00": 77.31999969482422,
      "2024-07-26T17:30:00+00:00": 77.23999786376953,
      "2024-07-26T18:30:00+00:00": 77.29010009765625,
      "2024-07-26T19:30:00+00:00": 77.23999786376953
    },
    "sentiment": 0.791819155216217
  },
  {
    "title": "Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024",
    "published": 1721937900,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 74.75,
      "2024-07-25T14:30:00+00:00": 76.97000122070312,
      "2024-07-25T15:30:00+00:00": 75.63999938964844,
      "2024-07-25T16:30:00+00:00": 76.322998046875,
      "2024-07-25T17:30:00+00:00": 76.1500015258789,
      "2024-07-25T18:30:00+00:00": 76.04000091552734,
      "2024-07-25T19:30:00+00:00": 76.62999725341797
    },
    "sentiment": 0.9389020204544067
  },
  {
    "title": "3 Stocks That Can Help You to Get Richer in 2024 and Beyond",
    "published": 1721902500,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 74.75,
      "2024-07-25T14:30:00+00:00": 76.97000122070312,
      "2024-07-25T15:30:00+00:00": 75.63999938964844,
      "2024-07-25T16:30:00+00:00": 76.322998046875,
      "2024-07-25T17:30:00+00:00": 76.1500015258789,
      "2024-07-25T18:30:00+00:00": 76.04000091552734,
      "2024-07-25T19:30:00+00:00": 76.62999725341797
    },
    "sentiment": 0.6787792444229126
  },
  {
    "title": "September 6th Options Now Available For Gilead Sciences (GILD)",
    "published": 1721901240,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 74.75,
      "2024-07-25T14:30:00+00:00": 76.97000122070312,
      "2024-07-25T15:30:00+00:00": 75.63999938964844,
      "2024-07-25T16:30:00+00:00": 76.322998046875,
      "2024-07-25T17:30:00+00:00": 76.1500015258789,
      "2024-07-25T18:30:00+00:00": 76.04000091552734,
      "2024-07-25T19:30:00+00:00": 76.62999725341797
    },
    "sentiment": 0.9442322850227356
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Gilead Sciences (GILD)",
    "published": 1721892060,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 74.75,
      "2024-07-25T14:30:00+00:00": 76.97000122070312,
      "2024-07-25T15:30:00+00:00": 75.63999938964844,
      "2024-07-25T16:30:00+00:00": 76.322998046875,
      "2024-07-25T17:30:00+00:00": 76.1500015258789,
      "2024-07-25T18:30:00+00:00": 76.04000091552734,
      "2024-07-25T19:30:00+00:00": 76.62999725341797
    },
    "sentiment": 0.7208796739578247
  },
  {
    "title": "Gilead Science Stock (NASDAQ:GILD): The Path to a $105 Price Target",
    "published": 1721870040,
    "day_prices": {
      "2024-07-25T13:30:00+00:00": 74.75,
      "2024-07-25T14:30:00+00:00": 76.97000122070312,
      "2024-07-25T15:30:00+00:00": 75.63999938964844,
      "2024-07-25T16:30:00+00:00": 76.322998046875,
      "2024-07-25T17:30:00+00:00": 76.1500015258789,
      "2024-07-25T18:30:00+00:00": 76.04000091552734,
      "2024-07-25T19:30:00+00:00": 76.62999725341797
    },
    "sentiment": 0.49648115038871765
  },
  {
    "title": "Gilead call volume above normal and directionally bullish",
    "published": 1721815320,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 71.66000366210938,
      "2024-07-24T14:30:00+00:00": 71.87000274658203,
      "2024-07-24T15:30:00+00:00": 72.4000015258789,
      "2024-07-24T16:30:00+00:00": 73.18000030517578,
      "2024-07-24T17:30:00+00:00": 73.06999969482422,
      "2024-07-24T18:30:00+00:00": 73.08999633789062,
      "2024-07-24T19:30:00+00:00": 73.27999877929688
    },
    "sentiment": 0.9002405405044556
  },
  {
    "title": "Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024",
    "published": 1721809800,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 71.66000366210938,
      "2024-07-24T14:30:00+00:00": 71.87000274658203,
      "2024-07-24T15:30:00+00:00": 72.4000015258789,
      "2024-07-24T16:30:00+00:00": 73.18000030517578,
      "2024-07-24T17:30:00+00:00": 73.06999969482422,
      "2024-07-24T18:30:00+00:00": 73.08999633789062,
      "2024-07-24T19:30:00+00:00": 73.27999877929688
    },
    "sentiment": 0.8672067523002625
  },
  {
    "title": "Gilead Sciences Now #102 Largest Company, Surpassing Synopsys",
    "published": 1721792760,
    "day_prices": {
      "2024-07-24T13:30:00+00:00": 71.66000366210938,
      "2024-07-24T14:30:00+00:00": 71.87000274658203,
      "2024-07-24T15:30:00+00:00": 72.4000015258789,
      "2024-07-24T16:30:00+00:00": 73.18000030517578,
      "2024-07-24T17:30:00+00:00": 73.06999969482422,
      "2024-07-24T18:30:00+00:00": 73.08999633789062,
      "2024-07-24T19:30:00+00:00": 73.27999877929688
    },
    "sentiment": 0.5457567572593689
  },
  {
    "title": "Gilead Sciences : Updated Statement on Global Access Planning for Lenacapavir for HIV Prevention",
    "published": 1721768975,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 71.86000061035156,
      "2024-07-23T14:30:00+00:00": 70.86499786376953,
      "2024-07-23T15:30:00+00:00": 71.19000244140625,
      "2024-07-23T16:30:00+00:00": 71.13999938964844,
      "2024-07-23T17:30:00+00:00": 71.33000183105469,
      "2024-07-23T18:30:00+00:00": 71.47000122070312,
      "2024-07-23T19:30:00+00:00": 71.2030029296875
    },
    "sentiment": 0.8212822675704956
  },
  {
    "title": "Viiv's Dovato as effective as Gilead' Biktarvy for HIV but with less weight gain",
    "published": 1721732400,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 71.86000061035156,
      "2024-07-23T14:30:00+00:00": 70.86499786376953,
      "2024-07-23T15:30:00+00:00": 71.19000244140625,
      "2024-07-23T16:30:00+00:00": 71.13999938964844,
      "2024-07-23T17:30:00+00:00": 71.33000183105469,
      "2024-07-23T18:30:00+00:00": 71.47000122070312,
      "2024-07-23T19:30:00+00:00": 71.2030029296875
    },
    "sentiment": 0.7432651519775391
  },
  {
    "title": "Gilead Sciences: A Balanced Outlook with Steady HIV Performance and Oncology Challenges Justifying a Hold Rating",
    "published": 1721707200,
    "day_prices": {
      "2024-07-23T13:30:00+00:00": 71.86000061035156,
      "2024-07-23T14:30:00+00:00": 70.86499786376953,
      "2024-07-23T15:30:00+00:00": 71.19000244140625,
      "2024-07-23T16:30:00+00:00": 71.13999938964844,
      "2024-07-23T17:30:00+00:00": 71.33000183105469,
      "2024-07-23T18:30:00+00:00": 71.47000122070312,
      "2024-07-23T19:30:00+00:00": 71.2030029296875
    },
    "sentiment": 0.9271348118782043
  },
  {
    "title": "UNAIDS boss calls on Gilead to provide \u2018miracle\u2019 drug to developing countries",
    "published": 1721670849,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 72.88999938964844,
      "2024-07-22T14:30:00+00:00": 72.1449966430664,
      "2024-07-22T15:30:00+00:00": 72.66000366210938,
      "2024-07-22T16:30:00+00:00": 72.44499969482422,
      "2024-07-22T17:30:00+00:00": 72.48500061035156,
      "2024-07-22T18:30:00+00:00": 72.19999694824219,
      "2024-07-22T19:30:00+00:00": 72.41999816894531
    },
    "sentiment": 0.6282134056091309
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Jasper Therapeutics (JSPR)",
    "published": 1721633520,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 72.88999938964844,
      "2024-07-22T14:30:00+00:00": 72.1449966430664,
      "2024-07-22T15:30:00+00:00": 72.66000366210938,
      "2024-07-22T16:30:00+00:00": 72.44499969482422,
      "2024-07-22T17:30:00+00:00": 72.48500061035156,
      "2024-07-22T18:30:00+00:00": 72.19999694824219,
      "2024-07-22T19:30:00+00:00": 72.41999816894531
    },
    "sentiment": 0.8990455865859985
  },
  {
    "title": "Biotech Bull Market Is Intact But SMIDs Are Too Volatile",
    "published": 1721614500,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 72.88999938964844,
      "2024-07-22T14:30:00+00:00": 72.1449966430664,
      "2024-07-22T15:30:00+00:00": 72.66000366210938,
      "2024-07-22T16:30:00+00:00": 72.44499969482422,
      "2024-07-22T17:30:00+00:00": 72.48500061035156,
      "2024-07-22T18:30:00+00:00": 72.19999694824219,
      "2024-07-22T19:30:00+00:00": 72.41999816894531
    },
    "sentiment": 0.7726059556007385
  },
  {
    "title": "UN urges Gilead to \"make history\" with game-changing HIV drug",
    "published": 1721609040,
    "day_prices": {
      "2024-07-22T13:30:00+00:00": 72.88999938964844,
      "2024-07-22T14:30:00+00:00": 72.1449966430664,
      "2024-07-22T15:30:00+00:00": 72.66000366210938,
      "2024-07-22T16:30:00+00:00": 72.44499969482422,
      "2024-07-22T17:30:00+00:00": 72.48500061035156,
      "2024-07-22T18:30:00+00:00": 72.19999694824219,
      "2024-07-22T19:30:00+00:00": 72.41999816894531
    },
    "sentiment": 0.8081246018409729
  },
  {
    "title": "Gilead Sciences' (NASDAQ:GILD) one-year decline in earnings translates into losses for shareholders",
    "published": 1721476813,
    "day_prices": {},
    "sentiment": 0.9723336100578308
  },
  {
    "title": "Jefferies Sticks to Their Buy Rating for Gilead Sciences (GILD)",
    "published": 1721373360,
    "day_prices": {
      "2024-07-19T13:30:00+00:00": 73.51000213623047,
      "2024-07-19T14:30:00+00:00": 72.2300033569336,
      "2024-07-19T15:30:00+00:00": 72.38999938964844,
      "2024-07-19T16:30:00+00:00": 72.44999694824219,
      "2024-07-19T17:30:00+00:00": 72.45999908447266,
      "2024-07-19T18:30:00+00:00": 72.75,
      "2024-07-19T19:30:00+00:00": 72.71499633789062
    },
    "sentiment": 0.8551303148269653
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1721307611,
    "day_prices": {
      "2024-07-18T13:30:00+00:00": 72.50199890136719,
      "2024-07-18T14:30:00+00:00": 74.19499969482422,
      "2024-07-18T15:30:00+00:00": 74.76000213623047,
      "2024-07-18T16:30:00+00:00": 74.48999786376953,
      "2024-07-18T17:30:00+00:00": 74.26499938964844,
      "2024-07-18T18:30:00+00:00": 73.7249984741211,
      "2024-07-18T19:30:00+00:00": 73.66680145263672
    },
    "sentiment": 0.9163755178451538
  },
  {
    "title": "Bullish On Vir Biotechnology's Innovative Pipeline That Targets HIV And Hepatitis",
    "published": 1721234846,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 72.01000213623047,
      "2024-07-17T14:30:00+00:00": 73.41999816894531,
      "2024-07-17T15:30:00+00:00": 72.02999877929688,
      "2024-07-17T16:30:00+00:00": 72.27999877929688,
      "2024-07-17T17:30:00+00:00": 72.5999984741211,
      "2024-07-17T18:30:00+00:00": 72.70999908447266,
      "2024-07-17T19:30:00+00:00": 72.9800033569336
    },
    "sentiment": 0.9133082032203674
  },
  {
    "title": "Want $3,000 In Passive Income? Invest $51,000 in These 3 High-Yield Dividend Plays",
    "published": 1721214900,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 72.01000213623047,
      "2024-07-17T14:30:00+00:00": 73.41999816894531,
      "2024-07-17T15:30:00+00:00": 72.02999877929688,
      "2024-07-17T16:30:00+00:00": 72.27999877929688,
      "2024-07-17T17:30:00+00:00": 72.5999984741211,
      "2024-07-17T18:30:00+00:00": 72.70999908447266,
      "2024-07-17T19:30:00+00:00": 72.9800033569336
    },
    "sentiment": 0.9446725249290466
  },
  {
    "title": "Gilead set to unveil data from HIV/AIDS trials",
    "published": 1721209948,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 72.01000213623047,
      "2024-07-17T14:30:00+00:00": 73.41999816894531,
      "2024-07-17T15:30:00+00:00": 72.02999877929688,
      "2024-07-17T16:30:00+00:00": 72.27999877929688,
      "2024-07-17T17:30:00+00:00": 72.5999984741211,
      "2024-07-17T18:30:00+00:00": 72.70999908447266,
      "2024-07-17T19:30:00+00:00": 72.9800033569336
    },
    "sentiment": 0.8432601094245911
  },
  {
    "title": "Gilead chief medical officer Merdad Parsey to depart early 2025",
    "published": 1721202960,
    "day_prices": {
      "2024-07-17T13:30:00+00:00": 72.01000213623047,
      "2024-07-17T14:30:00+00:00": 73.41999816894531,
      "2024-07-17T15:30:00+00:00": 72.02999877929688,
      "2024-07-17T16:30:00+00:00": 72.27999877929688,
      "2024-07-17T17:30:00+00:00": 72.5999984741211,
      "2024-07-17T18:30:00+00:00": 72.70999908447266,
      "2024-07-17T19:30:00+00:00": 72.9800033569336
    },
    "sentiment": 0.7491583228111267
  },
  {
    "title": "Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024",
    "published": 1721133000,
    "day_prices": {
      "2024-07-16T13:30:00+00:00": 70.33000183105469,
      "2024-07-16T14:30:00+00:00": 71.91500091552734,
      "2024-07-16T15:30:00+00:00": 71.86000061035156,
      "2024-07-16T16:30:00+00:00": 71.56999969482422,
      "2024-07-16T17:30:00+00:00": 71.62999725341797,
      "2024-07-16T18:30:00+00:00": 71.5999984741211,
      "2024-07-16T19:30:00+00:00": 71.63999938964844
    },
    "sentiment": 0.8136926293373108
  },
  {
    "title": "3 Underappreciated Stocks About to Break Their Chains",
    "published": 1720708200,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 68.45999908447266,
      "2024-07-11T14:30:00+00:00": 69.2300033569336,
      "2024-07-11T15:30:00+00:00": 69.93000030517578,
      "2024-07-11T16:30:00+00:00": 69.81999969482422,
      "2024-07-11T17:30:00+00:00": 70.01270294189453,
      "2024-07-11T18:30:00+00:00": 69.94999694824219,
      "2024-07-11T19:30:00+00:00": 69.75
    },
    "sentiment": 0.8790075182914734
  },
  {
    "title": "New HIV Drug Can Only Offer Hope of Ending Aids If All Have Access, UNAIDS Says",
    "published": 1720663571,
    "day_prices": {
      "2024-07-11T13:30:00+00:00": 68.45999908447266,
      "2024-07-11T14:30:00+00:00": 69.2300033569336,
      "2024-07-11T15:30:00+00:00": 69.93000030517578,
      "2024-07-11T16:30:00+00:00": 69.81999969482422,
      "2024-07-11T17:30:00+00:00": 70.01270294189453,
      "2024-07-11T18:30:00+00:00": 69.94999694824219,
      "2024-07-11T19:30:00+00:00": 69.75
    },
    "sentiment": 0.5724119544029236
  },
  {
    "title": "Pfizer signals progress on obesity pill, boosting stock",
    "published": 1720647060,
    "day_prices": {
      "2024-07-10T13:30:00+00:00": 67.7699966430664,
      "2024-07-10T14:30:00+00:00": 68.37000274658203,
      "2024-07-10T15:30:00+00:00": 68.08000183105469,
      "2024-07-10T16:30:00+00:00": 68.23999786376953,
      "2024-07-10T17:30:00+00:00": 68.69000244140625,
      "2024-07-10T18:30:00+00:00": 68.7249984741211,
      "2024-07-10T19:30:00+00:00": 68.5999984741211
    },
    "sentiment": 0.9509365558624268
  },
  {
    "title": "Gilead Gets Analyst Upgrade on 'Outstanding' HIV Treatment Data",
    "published": 1720454588,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 67.8499984741211,
      "2024-07-08T14:30:00+00:00": 67.97000122070312,
      "2024-07-08T15:30:00+00:00": 67.24829864501953,
      "2024-07-08T16:30:00+00:00": 67.4800033569336,
      "2024-07-08T17:30:00+00:00": 67.81999969482422,
      "2024-07-08T18:30:00+00:00": 67.65969848632812,
      "2024-07-08T19:30:00+00:00": 67.5199966430664
    },
    "sentiment": 0.9558560252189636
  },
  {
    "title": "Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal",
    "published": 1720441852,
    "day_prices": {
      "2024-07-08T13:30:00+00:00": 67.8499984741211,
      "2024-07-08T14:30:00+00:00": 67.97000122070312,
      "2024-07-08T15:30:00+00:00": 67.24829864501953,
      "2024-07-08T16:30:00+00:00": 67.4800033569336,
      "2024-07-08T17:30:00+00:00": 67.81999969482422,
      "2024-07-08T18:30:00+00:00": 67.65969848632812,
      "2024-07-08T19:30:00+00:00": 67.5199966430664
    },
    "sentiment": 0.871503472328186
  },
  {
    "title": "HIV Breakthrough - Drug Trial Shows Injection Twice a Year Is 100 Percent Effective Against Infection [analysis]",
    "published": 1720001170,
    "day_prices": {
      "2024-07-03T13:30:00+00:00": 68.23999786376953,
      "2024-07-03T14:30:00+00:00": 67.1500015258789,
      "2024-07-03T15:30:00+00:00": 67.18000030517578
    },
    "sentiment": 0.8436845541000366
  },
  {
    "title": "Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE?",
    "published": 1719918033,
    "day_prices": {
      "2024-07-02T13:30:00+00:00": 68.30010223388672,
      "2024-07-02T14:30:00+00:00": 67.91999816894531,
      "2024-07-02T15:30:00+00:00": 68.33999633789062,
      "2024-07-02T16:30:00+00:00": 68.13999938964844,
      "2024-07-02T17:30:00+00:00": 67.94000244140625,
      "2024-07-02T18:30:00+00:00": 68.11000061035156,
      "2024-07-02T19:30:00+00:00": 68.10870361328125
    },
    "sentiment": 0.7872440218925476
  },
  {
    "title": "Should You Hold Gilead Sciences (GILD)?",
    "published": 1719831348,
    "day_prices": {
      "2024-07-01T13:30:00+00:00": 68.62000274658203,
      "2024-07-01T14:30:00+00:00": 69.5999984741211,
      "2024-07-01T15:30:00+00:00": 68.9800033569336,
      "2024-07-01T16:30:00+00:00": 68.63999938964844,
      "2024-07-01T17:30:00+00:00": 68.69999694824219,
      "2024-07-01T18:30:00+00:00": 68.62999725341797,
      "2024-07-01T19:30:00+00:00": 68.58999633789062
    },
    "sentiment": 0.9406736493110657
  },
  {
    "title": "How Gilead Sciences, Virtus Investment And Hess Midstream Could Put Cash In Your Pocket",
    "published": 1725041109,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 79.43000030517578,
      "2024-08-30T14:30:00+00:00": 79.50019836425781,
      "2024-08-30T15:30:00+00:00": 78.94999694824219,
      "2024-08-30T16:30:00+00:00": 78.65499877929688,
      "2024-08-30T17:30:00+00:00": 78.87999725341797,
      "2024-08-30T18:30:00+00:00": 78.95500183105469,
      "2024-08-30T19:30:00+00:00": 79.19000244140625
    },
    "sentiment": 0.931510329246521
  },
  {
    "title": "Insider Sale: Johanna Mercier Sells 9,513 Shares of Gilead Sciences Inc (GILD)",
    "published": 1724996776,
    "day_prices": {
      "2024-08-30T13:30:00+00:00": 79.43000030517578,
      "2024-08-30T14:30:00+00:00": 79.50019836425781,
      "2024-08-30T15:30:00+00:00": 78.94999694824219,
      "2024-08-30T16:30:00+00:00": 78.65499877929688,
      "2024-08-30T17:30:00+00:00": 78.87999725341797,
      "2024-08-30T18:30:00+00:00": 78.95500183105469,
      "2024-08-30T19:30:00+00:00": 79.19000244140625
    },
    "sentiment": 0.9361132383346558
  },
  {
    "title": "Jefferies healthcare analyst holds an analyst/industry conference call",
    "published": 1724836140,
    "day_prices": {
      "2024-08-28T13:30:00+00:00": 77.45999908447266,
      "2024-08-28T14:30:00+00:00": 78.66000366210938,
      "2024-08-28T15:30:00+00:00": 78.83000183105469,
      "2024-08-28T16:30:00+00:00": 78.65499877929688,
      "2024-08-28T17:30:00+00:00": 78.80000305175781,
      "2024-08-28T18:30:00+00:00": 78.45999908447266,
      "2024-08-28T19:30:00+00:00": 78.72000122070312
    },
    "sentiment": 0.9385896325111389
  },
  {
    "title": "\"The Adventure Jar,\" Showcases a Family Navigating the Challenges of a Cancer Diagnosis and Finding Magic in Time Together",
    "published": 1724751129,
    "day_prices": {
      "2024-08-27T13:30:00+00:00": 77.20999908447266,
      "2024-08-27T14:30:00+00:00": 77.04000091552734,
      "2024-08-27T15:30:00+00:00": 77.08000183105469,
      "2024-08-27T16:30:00+00:00": 76.94999694824219,
      "2024-08-27T17:30:00+00:00": 76.9000015258789,
      "2024-08-27T18:30:00+00:00": 77.02999877929688,
      "2024-08-27T19:30:00+00:00": 77.18000030517578
    },
    "sentiment": 0.8927704095840454
  },
  {
    "title": "Exploring Three High Growth Tech Stocks in the United States",
    "published": 1724248952,
    "day_prices": {
      "2024-08-21T13:30:00+00:00": 74.8499984741211,
      "2024-08-21T14:30:00+00:00": 75.13999938964844,
      "2024-08-21T15:30:00+00:00": 75.17500305175781,
      "2024-08-21T16:30:00+00:00": 74.97000122070312,
      "2024-08-21T17:30:00+00:00": 75.08999633789062,
      "2024-08-21T18:30:00+00:00": 75.18000030517578,
      "2024-08-21T19:30:00+00:00": 75.06999969482422
    },
    "sentiment": 0.8611636757850647
  },
  {
    "title": "How To Earn $100 Per Month From Gilead Sciences Stock",
    "published": 1724176818,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 74.54000091552734,
      "2024-08-20T14:30:00+00:00": 74.66000366210938,
      "2024-08-20T15:30:00+00:00": 74.63999938964844,
      "2024-08-20T16:30:00+00:00": 74.62999725341797,
      "2024-08-20T17:30:00+00:00": 74.70950317382812,
      "2024-08-20T18:30:00+00:00": 74.86499786376953,
      "2024-08-20T19:30:00+00:00": 74.70999908447266
    },
    "sentiment": 0.9248924255371094
  },
  {
    "title": "Building a Bridge to a Healthier World for Youth in Africa with Gilead Sciences",
    "published": 1724157000,
    "day_prices": {
      "2024-08-20T13:30:00+00:00": 74.54000091552734,
      "2024-08-20T14:30:00+00:00": 74.66000366210938,
      "2024-08-20T15:30:00+00:00": 74.63999938964844,
      "2024-08-20T16:30:00+00:00": 74.62999725341797,
      "2024-08-20T17:30:00+00:00": 74.70950317382812,
      "2024-08-20T18:30:00+00:00": 74.86499786376953,
      "2024-08-20T19:30:00+00:00": 74.70999908447266
    },
    "sentiment": 0.5445349216461182
  },
  {
    "title": "PANTHERx Rare Partnering with Gilead Sciences, Inc. for the Distribution of LIVDELZI",
    "published": 1724060651,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 73.27999877929688,
      "2024-08-19T14:30:00+00:00": 74.2677001953125,
      "2024-08-19T15:30:00+00:00": 74.43000030517578,
      "2024-08-19T16:30:00+00:00": 74.26000213623047,
      "2024-08-19T17:30:00+00:00": 74.25,
      "2024-08-19T18:30:00+00:00": 74.2699966430664,
      "2024-08-19T19:30:00+00:00": 74.45999908447266
    },
    "sentiment": 0.5205971598625183
  },
  {
    "title": "Investor Reduces Stake in Guild Esports",
    "published": 1724031780,
    "day_prices": {
      "2024-08-19T13:30:00+00:00": 73.27999877929688,
      "2024-08-19T14:30:00+00:00": 74.2677001953125,
      "2024-08-19T15:30:00+00:00": 74.43000030517578,
      "2024-08-19T16:30:00+00:00": 74.26000213623047,
      "2024-08-19T17:30:00+00:00": 74.25,
      "2024-08-19T18:30:00+00:00": 74.2699966430664,
      "2024-08-19T19:30:00+00:00": 74.45999908447266
    },
    "sentiment": 0.5752778053283691
  },
  {
    "title": "Gilead (GILD) Obtains FDA Approval for PBC Drug Livdelzi",
    "published": 1723873440,
    "day_prices": {},
    "sentiment": 0.8479155898094177
  },
  {
    "title": "Why Gilead Sciences is a Top 25 Dividend Giant (GILD)",
    "published": 1723796340,
    "day_prices": {
      "2024-08-16T13:30:00+00:00": 74.0,
      "2024-08-16T14:30:00+00:00": 73.27999877929688,
      "2024-08-16T15:30:00+00:00": 73.62000274658203,
      "2024-08-16T16:30:00+00:00": 73.41000366210938,
      "2024-08-16T17:30:00+00:00": 73.90499877929688,
      "2024-08-16T18:30:00+00:00": 73.66000366210938,
      "2024-08-16T19:30:00+00:00": 73.54499816894531
    },
    "sentiment": 0.9035140872001648
  },
  {
    "title": "FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal",
    "published": 1723727357,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 74.30000305175781,
      "2024-08-15T14:30:00+00:00": 74.12999725341797,
      "2024-08-15T15:30:00+00:00": 74.31009674072266,
      "2024-08-15T16:30:00+00:00": 74.23999786376953,
      "2024-08-15T17:30:00+00:00": 73.94999694824219,
      "2024-08-15T18:30:00+00:00": 74.05000305175781,
      "2024-08-15T19:30:00+00:00": 74.2300033569336
    },
    "sentiment": 0.5648790001869202
  },
  {
    "title": "Gilead price target raised by $1 at Truist, here's why",
    "published": 1723718880,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 74.30000305175781,
      "2024-08-15T14:30:00+00:00": 74.12999725341797,
      "2024-08-15T15:30:00+00:00": 74.31009674072266,
      "2024-08-15T16:30:00+00:00": 74.23999786376953,
      "2024-08-15T17:30:00+00:00": 73.94999694824219,
      "2024-08-15T18:30:00+00:00": 74.05000305175781,
      "2024-08-15T19:30:00+00:00": 74.2300033569336
    },
    "sentiment": 0.7022056579589844
  },
  {
    "title": "Hold Rating on Gilead Sciences Amid Modest PBC Market Impact",
    "published": 1723699800,
    "day_prices": {
      "2024-08-15T13:30:00+00:00": 74.30000305175781,
      "2024-08-15T14:30:00+00:00": 74.12999725341797,
      "2024-08-15T15:30:00+00:00": 74.31009674072266,
      "2024-08-15T16:30:00+00:00": 74.23999786376953,
      "2024-08-15T17:30:00+00:00": 73.94999694824219,
      "2024-08-15T18:30:00+00:00": 74.05000305175781,
      "2024-08-15T19:30:00+00:00": 74.2300033569336
    },
    "sentiment": 0.6307821869850159
  },
  {
    "title": "Gilead\u2019s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDA",
    "published": 1723658340,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 73.73999786376953,
      "2024-08-14T14:30:00+00:00": 73.22000122070312,
      "2024-08-14T15:30:00+00:00": 73.86000061035156,
      "2024-08-14T16:30:00+00:00": 74.12000274658203,
      "2024-08-14T17:30:00+00:00": 73.93000030517578,
      "2024-08-14T18:30:00+00:00": 74.04000091552734,
      "2024-08-14T19:30:00+00:00": 74.16000366210938
    },
    "sentiment": 0.9451159238815308
  },
  {
    "title": "Merus: Great European Oncology Developer, But Properly Valued",
    "published": 1723655594,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 73.73999786376953,
      "2024-08-14T14:30:00+00:00": 73.22000122070312,
      "2024-08-14T15:30:00+00:00": 73.86000061035156,
      "2024-08-14T16:30:00+00:00": 74.12000274658203,
      "2024-08-14T17:30:00+00:00": 73.93000030517578,
      "2024-08-14T18:30:00+00:00": 74.04000091552734,
      "2024-08-14T19:30:00+00:00": 74.16000366210938
    },
    "sentiment": 0.8995041847229004
  },
  {
    "title": "Nkarta: NK Cell Therapy Biotech With Good Standing Targeting R/R NHL Patients",
    "published": 1723648123,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 73.73999786376953,
      "2024-08-14T14:30:00+00:00": 73.22000122070312,
      "2024-08-14T15:30:00+00:00": 73.86000061035156,
      "2024-08-14T16:30:00+00:00": 74.12000274658203,
      "2024-08-14T17:30:00+00:00": 73.93000030517578,
      "2024-08-14T18:30:00+00:00": 74.04000091552734,
      "2024-08-14T19:30:00+00:00": 74.16000366210938
    },
    "sentiment": 0.7176746726036072
  },
  {
    "title": "Gilead?s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDA",
    "published": 1723643940,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 73.73999786376953,
      "2024-08-14T14:30:00+00:00": 73.22000122070312,
      "2024-08-14T15:30:00+00:00": 73.86000061035156,
      "2024-08-14T16:30:00+00:00": 74.12000274658203,
      "2024-08-14T17:30:00+00:00": 73.93000030517578,
      "2024-08-14T18:30:00+00:00": 74.04000091552734,
      "2024-08-14T19:30:00+00:00": 74.16000366210938
    },
    "sentiment": 0.94603031873703
  },
  {
    "title": "FDA posts approval of Gilead liver disease drug Livdelzi",
    "published": 1723637220,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 73.73999786376953,
      "2024-08-14T14:30:00+00:00": 73.22000122070312,
      "2024-08-14T15:30:00+00:00": 73.86000061035156,
      "2024-08-14T16:30:00+00:00": 74.12000274658203,
      "2024-08-14T17:30:00+00:00": 73.93000030517578,
      "2024-08-14T18:30:00+00:00": 74.04000091552734,
      "2024-08-14T19:30:00+00:00": 74.16000366210938
    },
    "sentiment": 0.7977333664894104
  },
  {
    "title": "Gilead Sciences: A Strong Buy on Solid Financials and Promising R&D Pipeline",
    "published": 1723602960,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 73.73999786376953,
      "2024-08-14T14:30:00+00:00": 73.22000122070312,
      "2024-08-14T15:30:00+00:00": 73.86000061035156,
      "2024-08-14T16:30:00+00:00": 74.12000274658203,
      "2024-08-14T17:30:00+00:00": 73.93000030517578,
      "2024-08-14T18:30:00+00:00": 74.04000091552734,
      "2024-08-14T19:30:00+00:00": 74.16000366210938
    },
    "sentiment": 0.9547208547592163
  },
  {
    "title": "Gilead confirms FDA approval of Livdelzi for primary biliary cholangitis",
    "published": 1723597560,
    "day_prices": {
      "2024-08-14T13:30:00+00:00": 73.73999786376953,
      "2024-08-14T14:30:00+00:00": 73.22000122070312,
      "2024-08-14T15:30:00+00:00": 73.86000061035156,
      "2024-08-14T16:30:00+00:00": 74.12000274658203,
      "2024-08-14T17:30:00+00:00": 73.93000030517578,
      "2024-08-14T18:30:00+00:00": 74.04000091552734,
      "2024-08-14T19:30:00+00:00": 74.16000366210938
    },
    "sentiment": 0.9047718048095703
  },
  {
    "title": "Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership To Help Address the Growing HIV Crisis in Eastern Europe and Central Asia",
    "published": 1723553100,
    "day_prices": {
      "2024-08-13T13:30:00+00:00": 73.0,
      "2024-08-13T14:30:00+00:00": 73.2699966430664,
      "2024-08-13T15:30:00+00:00": 73.87950134277344,
      "2024-08-13T16:30:00+00:00": 74.12999725341797,
      "2024-08-13T17:30:00+00:00": 74.05999755859375,
      "2024-08-13T18:30:00+00:00": 73.9000015258789,
      "2024-08-13T19:30:00+00:00": 74.0199966430664
    },
    "sentiment": 0.885186493396759
  },
  {
    "title": "Is Gilead Sciences (NASDAQ:GILD) A Risky Investment?",
    "published": 1723381216,
    "day_prices": {},
    "sentiment": 0.7070552706718445
  },
  {
    "title": "These Stocks Moved the Most Today: Expedia, Akamai, Lilly, E.l.f. Beauty, Doximity, Rocket Lab, Five9, Array, and More",
    "published": 1723235640,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.8328686356544495
  },
  {
    "title": "These Stocks Are Moving the Most Today: Expedia, Paramount, Akamai, E.l.f. Beauty, Doximity, Rocket Lab, Gilead, and More",
    "published": 1723198260,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.8366173505783081
  },
  {
    "title": "Gilead Stock Dips As 'Non-Core' Products Drive Its Second-Quarter Beat",
    "published": 1723213164,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.971960723400116
  },
  {
    "title": "Video: Daily Dividend Report: GILD, WY, TSN, TRU, SNA",
    "published": 1723200360,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.9434168338775635
  },
  {
    "title": "Gilead Sciences (GILD) Gets a Buy from Evercore ISI",
    "published": 1723193580,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.6880524754524231
  },
  {
    "title": "4 stocks to watch on Friday: TSM, TTWO and more",
    "published": 1723192200,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.9162054061889648
  },
  {
    "title": "Gilead price target lowered by $10 at Oppenheimer, here's why",
    "published": 1723185720,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.8149299025535583
  },
  {
    "title": "Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight",
    "published": 1723180342,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.8826709389686584
  },
  {
    "title": "GLOBAL BRIEFING: China consumer price inflation picks up in July",
    "published": 1723163400,
    "day_prices": {
      "2024-08-09T13:30:00+00:00": 74.94000244140625,
      "2024-08-09T14:30:00+00:00": 74.04499816894531,
      "2024-08-09T15:30:00+00:00": 73.56999969482422,
      "2024-08-09T16:30:00+00:00": 73.3499984741211,
      "2024-08-09T17:30:00+00:00": 73.58000183105469,
      "2024-08-09T18:30:00+00:00": 73.36000061035156,
      "2024-08-09T19:30:00+00:00": 73.19000244140625
    },
    "sentiment": 0.7154620289802551
  },
  {
    "title": "Gilead Hikes Profit Outlook As Biggest HIV Drug Outperforms Expectations",
    "published": 1723151784,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.9314497709274292
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) Q2 2024 Earnings Call Transcript",
    "published": 1723150024,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.9003081917762756
  },
  {
    "title": "Gilead: Q2 Earnings Snapshot",
    "published": 1723147908,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.6298720240592957
  },
  {
    "title": "Gilead Sciences Announces Second Quarter 2024 Financial Results",
    "published": 1723147320,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.89620041847229
  },
  {
    "title": "Gilead Sciences : Second Quarter 2024 Supplementary Information",
    "published": 1723136095,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.9373999834060669
  },
  {
    "title": "TOP NEWS: Gilead cuts guidance despite second quarter earnings bump",
    "published": 1723135500,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.9667184948921204
  },
  {
    "title": "GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q2 2024",
    "published": 1723104120,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.6456824541091919
  },
  {
    "title": "Gilead quarterly results beat on both lines and raises full-year non-GAAP EPS outlook",
    "published": 1723090500,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.9280452132225037
  },
  {
    "title": "Gilead Sciences in charts: Sales from HIV, Liver Disease, and Oncology therapies advances in Q2",
    "published": 1723087440,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.9459272623062134
  },
  {
    "title": "Gilead jumps 2% to $77.30 following Q2 beat",
    "published": 1723086360,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.940506637096405
  },
  {
    "title": "Gilead reports Q2 EPS $2.01, consensus $1.60",
    "published": 1723086240,
    "day_prices": {
      "2024-08-08T13:30:00+00:00": 74.05000305175781,
      "2024-08-08T14:30:00+00:00": 75.01000213623047,
      "2024-08-08T15:30:00+00:00": 75.23999786376953,
      "2024-08-08T16:30:00+00:00": 75.37000274658203,
      "2024-08-08T17:30:00+00:00": 75.52999877929688,
      "2024-08-08T18:30:00+00:00": 75.52999877929688,
      "2024-08-08T19:30:00+00:00": 75.31999969482422
    },
    "sentiment": 0.5598457455635071
  },
  {
    "title": "Gilead Sciences Q2 Earnings Preview: Focus on CAR-T market and oncology",
    "published": 1723034400,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 74.51000213623047,
      "2024-08-07T14:30:00+00:00": 74.91000366210938,
      "2024-08-07T15:30:00+00:00": 74.9800033569336,
      "2024-08-07T16:30:00+00:00": 74.75,
      "2024-08-07T17:30:00+00:00": 74.5199966430664,
      "2024-08-07T18:30:00+00:00": 74.3499984741211,
      "2024-08-07T19:30:00+00:00": 74.37999725341797
    },
    "sentiment": 0.9345542192459106
  },
  {
    "title": "Tango Therapeutics reports Q2 EPS (24c), consensus (34c)",
    "published": 1723012140,
    "day_prices": {
      "2024-08-07T13:30:00+00:00": 74.51000213623047,
      "2024-08-07T14:30:00+00:00": 74.91000366210938,
      "2024-08-07T15:30:00+00:00": 74.9800033569336,
      "2024-08-07T16:30:00+00:00": 74.75,
      "2024-08-07T17:30:00+00:00": 74.5199966430664,
      "2024-08-07T18:30:00+00:00": 74.3499984741211,
      "2024-08-07T19:30:00+00:00": 74.37999725341797
    },
    "sentiment": 0.8894169330596924
  },
  {
    "title": "$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today",
    "published": 1722942300,
    "day_prices": {
      "2024-08-06T13:30:00+00:00": 74.5,
      "2024-08-06T14:30:00+00:00": 75.0199966430664,
      "2024-08-06T15:30:00+00:00": 75.11000061035156,
      "2024-08-06T16:30:00+00:00": 74.9000015258789,
      "2024-08-06T17:30:00+00:00": 74.94000244140625,
      "2024-08-06T18:30:00+00:00": 75.12999725341797,
      "2024-08-06T19:30:00+00:00": 74.6500015258789
    },
    "sentiment": 0.9081998467445374
  },
  {
    "title": "Gilead's New Anti-Obesity Drug: The Real Reason Behind The 25% Stock Surge?",
    "published": 1722864622,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 77.12000274658203,
      "2024-08-05T14:30:00+00:00": 74.83999633789062,
      "2024-08-05T15:30:00+00:00": 74.94499969482422,
      "2024-08-05T16:30:00+00:00": 75.0199966430664,
      "2024-08-05T17:30:00+00:00": 74.92500305175781,
      "2024-08-05T18:30:00+00:00": 75.16000366210938,
      "2024-08-05T19:30:00+00:00": 74.93000030517578
    },
    "sentiment": 0.8277134895324707
  },
  {
    "title": "Matrix Asset Advisors Q2 2024 Capital Markets Commentary And Quarterly Report",
    "published": 1722861900,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 77.12000274658203,
      "2024-08-05T14:30:00+00:00": 74.83999633789062,
      "2024-08-05T15:30:00+00:00": 74.94499969482422,
      "2024-08-05T16:30:00+00:00": 75.0199966430664,
      "2024-08-05T17:30:00+00:00": 74.92500305175781,
      "2024-08-05T18:30:00+00:00": 75.16000366210938,
      "2024-08-05T19:30:00+00:00": 74.93000030517578
    },
    "sentiment": 0.9335716366767883
  },
  {
    "title": "LONDON MARKET MIDDAY: Europe slumps amid \"brutal\" global sell off",
    "published": 1722841440,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 77.12000274658203,
      "2024-08-05T14:30:00+00:00": 74.83999633789062,
      "2024-08-05T15:30:00+00:00": 74.94499969482422,
      "2024-08-05T16:30:00+00:00": 75.0199966430664,
      "2024-08-05T17:30:00+00:00": 74.92500305175781,
      "2024-08-05T18:30:00+00:00": 75.16000366210938,
      "2024-08-05T19:30:00+00:00": 74.93000030517578
    },
    "sentiment": 0.968435525894165
  },
  {
    "title": "LONDON MARKET OPEN: FTSE 100 sinks as global markets in turmoil",
    "published": 1722830460,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 77.12000274658203,
      "2024-08-05T14:30:00+00:00": 74.83999633789062,
      "2024-08-05T15:30:00+00:00": 74.94499969482422,
      "2024-08-05T16:30:00+00:00": 75.0199966430664,
      "2024-08-05T17:30:00+00:00": 74.92500305175781,
      "2024-08-05T18:30:00+00:00": 75.16000366210938,
      "2024-08-05T19:30:00+00:00": 74.93000030517578
    },
    "sentiment": 0.6947182416915894
  },
  {
    "title": "Guild Esports Announces Potential Sale to DCB Sports",
    "published": 1722823320,
    "day_prices": {
      "2024-08-05T13:30:00+00:00": 77.12000274658203,
      "2024-08-05T14:30:00+00:00": 74.83999633789062,
      "2024-08-05T15:30:00+00:00": 74.94499969482422,
      "2024-08-05T16:30:00+00:00": 75.0199966430664,
      "2024-08-05T17:30:00+00:00": 74.92500305175781,
      "2024-08-05T18:30:00+00:00": 75.16000366210938,
      "2024-08-05T19:30:00+00:00": 74.93000030517578
    },
    "sentiment": 0.9281265139579773
  },
  {
    "title": "Q3\u2019s Rising Stars: 3 Nasdaq Stocks for Your Must-Watch List",
    "published": 1722627188,
    "day_prices": {
      "2024-08-02T13:30:00+00:00": 77.80000305175781,
      "2024-08-02T14:30:00+00:00": 77.28500366210938,
      "2024-08-02T15:30:00+00:00": 75.83999633789062,
      "2024-08-02T16:30:00+00:00": 76.52999877929688,
      "2024-08-02T17:30:00+00:00": 76.11000061035156,
      "2024-08-02T18:30:00+00:00": 76.05500030517578,
      "2024-08-02T19:30:00+00:00": 76.08000183105469
    },
    "sentiment": 0.9133265018463135
  },
  {
    "title": "Gilead Sciences (GILD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "published": 1722520882,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 76.12000274658203,
      "2024-08-01T14:30:00+00:00": 76.44999694824219,
      "2024-08-01T15:30:00+00:00": 76.52999877929688,
      "2024-08-01T16:30:00+00:00": 76.7300033569336,
      "2024-08-01T17:30:00+00:00": 76.9800033569336,
      "2024-08-01T18:30:00+00:00": 76.72000122070312,
      "2024-08-01T19:30:00+00:00": 76.80000305175781
    },
    "sentiment": 0.922757625579834
  },
  {
    "title": "GILD September 13th Options Begin Trading",
    "published": 1722485820,
    "day_prices": {
      "2024-08-01T13:30:00+00:00": 76.12000274658203,
      "2024-08-01T14:30:00+00:00": 76.44999694824219,
      "2024-08-01T15:30:00+00:00": 76.52999877929688,
      "2024-08-01T16:30:00+00:00": 76.7300033569336,
      "2024-08-01T17:30:00+00:00": 76.9800033569336,
      "2024-08-01T18:30:00+00:00": 76.72000122070312,
      "2024-08-01T19:30:00+00:00": 76.80000305175781
    },
    "sentiment": 0.9371291995048523
  }
]